Research Article
COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing’s Sarcoma
Table 3
Relationship between the expression level of COL1A2 and clinical characteristics in ES.
| Characteristic | Low expression of COL1A2 | High expression of COL1A2 | |
| | 50 | 51 | | Metastasis, (%) | | | 1.000 | No | 38 (37.6%) | 38 (37.6%) | | Yes | 12 (11.9%) | 13 (12.9%) | | Tumor region, (%) | | | 0.360 | Distal | 18 (28.1%) | 18 (28.1%) | | Other | 3 (4.7%) | 0 (0%) | | Proximal | 13 (20.3%) | 12 (18.8%) | | Proximal and distal | 0 (0%) | 0 (0%) | | Age, (%) | | | 0.139 | <18 | 35 (34.7%) | 43 (42.6%) | | ≥18 | 15 (14.9%) | 8 (7.9%) | | Gender, (%) | | | 0.626 | Female | 22 (21.8%) | 19 (18.8%) | | Male | 28 (27.7%) | 32 (31.7%) | | Race, (%) | | | | American Indian or Alaska Native | 1 (1.3%) | 0 (0%) | | Asian | 5 (6.6%) | 2 (2.6%) | | Black or African American | 6 (7.9%) | 4 (5.3%) | | Native Hawaiian or other Pacific Islander | 0 (0%) | 0 (0%) | | White | 26 (34.2%) | 32 (42.1%) | | Age, median (IQR) | 15.52 (12.76, 18.8) | 13.87 (11.87, 16.65) | 0.111 |
|
|